The manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer previously received information alleging an issue related to a cpap device's sound abatement foam.The patient alleged experiencing sinusitis, burning eyes, and throat discomfort while using the device.And required steroid prescription.The device was returned to the manufacturer's product investigation laboratory for investigation.During the investigation, evidence of sound abatement foam degradation or breakdown was not observed in the base unit.Observed dust/dirt contamination on top and bottom enclosures, ui panel, rear panel, sd cover flip door, accessory module flip door, control dial, keypad, blower, blower box, blower grommets, blower outlet seal, p4 power connector.An unknown contaminate was observed inside the ui panel.A contaminate consistent with keratin was observed on the blower box.The device's downloaded event log was reviewed by the manufacturer and found no errors.The manufacturer concludes that unable to directly address the symptoms outlined in the complaint.Observe dust/dirt contamination in the airpath, likely from a source external to the device.Observed no evidence of degraded sound abatement foam.Section h6 health effects - clinical code was missed to capture in the previous report.It has been updated or corrected in this report. in this report, sections d9, g3, h3, and h6 have been updated or corrected.
|